Spectrum Reporting Prompts New Review of Common Drug

The review of more than two dozen studies finds aripiprazole has side effects and does not change core autism features, but parents report improvements in self-injury, tantrums, and other challenging behaviors.

Written byJaclyn Jeffrey-Wilensky
| 3 min read
aripiprazole ability autism spectrum behavior review

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, DNY59

Aripiprazole, a commonly used antipsychotic medication marketed as Abilify, curtails aggressive behavior in autistic children, according to a new review, but not enough is known about the drug’s side effects or its efficacy in different populations.

A feature in Spectrum last year prompted the new review, says Alan Poling, lead investigator and professor of psychology at Western Michigan University in Kalamazoo.

“The Spectrum article caused us to ask ourselves: Did we miss something?” he says. “That focused our attention on the literature.”

Poling and his colleagues scoured PubMed, Scopus, and Web of Science for articles containing the terms “aripiprazole” and “autism spectrum disorder.” They winnowed the 500-plus results down to a list of 12 review articles and 14 original studies. None suggested that aripiprazole changes core autism features, such as social-communication difficulties or restricted and repetitive behaviors.

Autistic children and teenagers taking aripiprazole improved more than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies